2-Hydroxyquinoxaline - CAS 1196-57-2
Catalog: |
BB004568 |
Product Name: |
2-Hydroxyquinoxaline |
CAS: |
1196-57-2 |
Synonyms: |
quinoxalin-2-ol; 2(1H)-Quinoxalinone |
Application: |
2-Quinoxalinone is a metabolite of Quinalphos, and is known to photocatalytically destroy antioxidant vitamins and biogenic amines in vitro and is genotoxic to both light- and dark-exposed bacteria. |
IUPAC Name: | 1H-quinoxalin-2-one |
Description: | 2-Hydroxyquinoxaline (CAS# 1196-57-2) is a metabolite of Quinalphos, and is known to photocatalytically destroy antioxidant vitamins and biogenic amines in vitro and is genotoxic to both light- and dark-exposed bacteria. |
Molecular Weight: | 146.15 |
Molecular Formula: | C8H6N2O |
Canonical SMILES: | C1=CC=C2C(=C1)NC(=O)C=N2 |
InChI: | InChI=1S/C8H6N2O/c11-8-5-9-6-3-1-2-4-7(6)10-8/h1-5H,(H,10,11) |
InChI Key: | FFRYUAVNPBUEIC-UHFFFAOYSA-N |
Boiling Point: | 363.4 °C at 760 mmHg |
Purity: | > 95 % |
Density: | 1.31 g/cm3 |
Solubility: | Methanol; DMSO |
Storage: | Sealed in dry, Room Temperature |
MDL: | MFCD00006722 |
LogP: | 1.33540 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-113264923-A | Synthesis method of 3-gamma-lactam/acylamino alkyl substituted quinoxalinone derivative | 20210608 |
CN-113372215-A | Novel esterification method for synthesizing p-halomethyl benzoate | 20210520 |
CN-113024625-A | Preparation method of 7-ketone-cholesterol acetate | 20210325 |
CN-112812069-A | Synthetic method of 3-methyl-3-quinolol | 20210221 |
CN-112961112-A | (Z) -enaminone compound and synthesis method thereof | 20210221 |
PMID | Publication Date | Title | Journal |
23338979 | 20130401 | Biological assay of a novel quinoxalinone with antimalarial efficacy on Plasmodium yoelii yoelii | Parasitology research |
23256033 | 20121213 | A Potent and Selective Quinoxalinone-Based STK33 Inhibitor Does Not Show Synthetic Lethality in KRAS-Dependent Cells | ACS medicinal chemistry letters |
22563758 | 20120518 | Allylic C-H activations using Cu(II) 2-quinoxalinol salen and tert-butyl hydroperoxide | The Journal of organic chemistry |
22416050 | 20120501 | An efficient synthesis of quinoxalinone derivatives as potent inhibitors of aldose reductase | ChemMedChem |
22356742 | 20120430 | In vitro and in vivo studies on degradation of quinalphos in rats | Journal of hazardous materials |
Complexity: | 200 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 146.048012819 |
Formal Charge: | 0 |
Heavy Atom Count: | 11 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 146.048012819 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 41.5 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.8 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Quinoxalines
Customers Also Viewed
-
[16208-48-3]
Ethanesulfonic acid, 2,2'-trithiodi-, disodium salt
-
[55408-10-1]
Ethyl Tetrazole-5-carboxylate
-
[104517-96-6]
Ioversol related compound B
-
[3821-81-6]
3-Amino-2-fluoropropionic acid
-
[1808-26-0]
Ethyl arachidonate
-
[132182-92-4]
Pentane, 1,1,1,2,2,3,4,5,5,5-decafluoro-3-methoxy-4-(trifluoromethyl)-
INDUSTRY LEADERS TRUST OUR PRODUCTS